OTC Markets OTCQX - Delayed Quote USD
Roche Holding AG (RHHBF)
355.38
0.00
(0.00%)
At close: April 24 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in CHF | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 18 | 18 |
| Avg. Estimate | 15.34B | 15.95B | 63.93B | 66.74B |
| Low Estimate | 15.23B | 15.95B | 60.74B | 63.72B |
| High Estimate | 15.44B | 15.95B | 66.44B | 70.34B |
| Year Ago Sales | 14.4B | 15.45B | 60.49B | 63.93B |
| Sales Growth (year/est) | 6.54% | 3.24% | 5.68% | 4.40% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| RHHBF | -- | -- | -- | -- |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Related Tickers
NVSEF Novartis AG
111.41
0.00%
NONOF Novo Nordisk A/S
61.55
-3.15%
AZNCF AstraZeneca PLC
137.24
0.00%
CMOPF Cosmo Pharmaceuticals N.V.
55.00
0.00%
ZEG.SG AstraZeneca PLC
122.90
+1.11%
OPHLF Ono Pharmaceutical Co., Ltd.
11.81
0.00%
NOVOBc.XC
PFE.CL Pfizer Inc.
97,340.00
+1.08%
JNJ.BA Johnson & Johnson
12,400.00
+1.22%
LLY.SW Eli Lilly and Company
675.00
0.00%